XNAS 23 Oct, 2026 2:14 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.68 per share. | 09 Sep 2026 | 120,000 | 140,411 | - | 15.7 | 1,882,104 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share. | 09 Sep 2026 | 150,000 | 260,411 | - | 1.0 | 144,570 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 09 Sep 2026 | 150,000 | 100,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 03 Sep 2026 | 25,000 | 193,067 | - | 0.6 | 15,000 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 03 Sep 2026 | 25,000 | 168,067 | - | 15.0 | 375,010 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | 03 Sep 2026 | 25,000 | 256,250 | - | - | Employee Stock Option (Right to Buy) | ||
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.89 per share. | 20 Aug 2026 | 3,860 | 168,067 | - | 16.9 | 65,187 | Common Stock |
| Mr. David Rivas | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 16.79 per share. | 20 Aug 2026 | 9,038 | 316,907 | - | 16.8 | 151,734 | Common Stock |
| Dr. Andrew Joseph Bestwick, PhD | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 18 Aug 2026 | 5,791 | 1,036,121 | - | 16.8 | 97,319 | Common Stock |
| Dr. Andrew Joseph Bestwick, PhD | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2026 | 750,000 | 1,041,912 | - | 0 | Common Stock | |
| Dr. Ray Johnson, PhD | Director | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 22 Jun 2026 | 84,944 | 95,537 | - | 20.5 | 1,745,242 | Common Stock |
| Mr. Michael S. Clifton | Director | 12 Jun 2026 | 94,733 | 0 | - | - | Warrants (right to buy) | ||
| Mr. Michael S. Clifton | Director | 12 Jun 2026 | 4,361 | 94,733 | - | - | Warrants (right to buy) | ||
| Mr. Thomas J. Iannotti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 9,208 | 24,110 | - | 0 | Common Stock | |
| Mr. Michael S. Clifton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 9,208 | 512,974 | - | 0 | Common Stock | |
| Dr. Alissa M. Fitzgerald, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 9,208 | 43,882 | - | 0 | Common Stock | |
| Dr. Ray Johnson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2026 | 9,208 | 180,481 | - | 0 | Common Stock | |
| Dr. Ray Johnson, PhD | Director | Sale of securities on an exchange or to another person at price $ 21.76 per share. | 08 Jun 2026 | 5,971 | 171,273 | - | 21.8 | 129,953 | Common Stock |
| Dr. Ray Johnson, PhD | Director | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 08 Jun 2026 | 116,217 | 177,244 | - | 21.3 | 2,472,889 | Common Stock |
| Mr. Michael S. Clifton | Director | 02 Jun 2026 | 3,144 | 153,106 | - | - | Warrants (right to buy) | ||
| Mr. Michael S. Clifton | Director | 02 Jun 2026 | 54,012 | 99,094 | - | - | Warrants (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 29 May 2026 | 75,131 | 788,286 | - | 0.3 | 20,436 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | 29 May 2026 | 393 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | 29 May 2026 | 3,541 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | 29 May 2026 | 33,053 | 61,385 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | 29 May 2026 | 75,131 | 209,851 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 25.40 per share. | 29 May 2026 | 499,328 | 325,945 | - | 25.4 | 12,680,934 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 29 May 2026 | 393 | 825,273 | - | 0.3 | 107 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 29 May 2026 | 3,541 | 824,880 | - | 0.3 | 963 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 29 May 2026 | 33,053 | 821,339 | - | 0.3 | 8,990 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 28 May 2026 | 33,490 | 966,510 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share. | 28 May 2026 | 70,000 | 70,000 | - | 1.0 | 67,466 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 28 May 2026 | 111,111 | 181,111 | - | 1.1 | 116,667 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 28 May 2026 | 33,490 | 214,601 | - | 1.4 | 47,221 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 28 May 2026 | 43,190 | 171,411 | - | 26.2 | 1,132,839 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 28 May 2026 | 61,000 | 110,411 | - | 24.4 | 1,487,064 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 28 May 2026 | 70,000 | 430,000 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 28 May 2026 | 111,111 | 888,889 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.62 per share. | 22 May 2026 | 13 | 171,927 | - | 25.6 | 333 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.94 per share. | 22 May 2026 | 3,669 | 171,940 | - | 22.9 | 84,156 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 25.63 per share. | 22 May 2026 | 30 | 713,155 | - | 25.6 | 769 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 22.95 per share. | 22 May 2026 | 18,729 | 713,185 | - | 23.0 | 429,874 | Common Stock |
| Mr. Michael S. Clifton | Director | 21 May 2026 | 50,000 | 156,250 | - | - | Warrants (right to buy) | ||
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | 10 Mar 2026 | 180,000 | 180,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.52 per share. | 10 Mar 2026 | 4,270 | 175,609 | - | 17.5 | 74,804 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 10 Mar 2026 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 17.52 per share. | 10 Mar 2026 | 36,719 | 651,914 | - | 17.5 | 643,321 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 80,000 | 731,914 | - | 0 | Common Stock | |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 17.52 per share. | 10 Mar 2026 | 36,719 | 651,914 | - | 17.5 | 643,321 | - |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 80,000 | 731,914 | - | 0 | - | |
| Mr. Michael S. Clifton | Director | 09 Feb 2026 | 50,000 | 206,250 | - | - | Warrants (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 22.41 per share. | 02 Jan 2026 | 59,316 | 34,675 | - | 22.4 | 1,329,378 | Common Stock |
| Ms. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 22.41 per share. | 02 Jan 2026 | 59,316 | 34,675 | - | 22.4 | 1,329,378 | - |
| Mr. Michael S. Clifton | Director | 09 Dec 2025 | 35,725 | 256,250 | - | - | Warrants (right to buy) | ||
| Mr. Michael S. Clifton | Director | 09 Dec 2025 | 64,275 | 291,975 | - | - | Warrants (right to buy) | ||
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 27.34 per share. | 09 Dec 2025 | 150,000 | 503,766 | - | 27.3 | 4,100,805 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.35 per share. | 20 Nov 2025 | 3,702 | 179,879 | - | 26.4 | 97,551 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 26.34 per share. | 20 Nov 2025 | 41,935 | 688,633 | - | 26.3 | 1,104,555 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 44.89 per share. | 17 Oct 2025 | 62,000 | 120,371 | - | 44.9 | 2,782,889 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 24.75 per share. | 19 Sep 2025 | 17,634 | 182,371 | - | 24.7 | 436,413 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 19 Sep 2025 | 1 | 200,005 | - | 27 | 27 | Common Stock |
| Mr. Michael S. Clifton | Director | 17 Sep 2025 | 100,000 | 356,250 | - | - | Warrants (Right to Buy) | ||
| Mr. Thomas J. Iannotti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. | 12 Sep 2025 | 100,000 | 114,902 | - | 1.2 | 117,000 | Common Stock |
| Mr. Thomas J. Iannotti | Director | 12 Sep 2025 | 100,000 | 520,000 | - | - | Stock Option (Right to Buy) | ||
| Mr. Thomas J. Iannotti | Director | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 12 Sep 2025 | 100,000 | 14,902 | - | 19.5 | 1,950,020 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 12 Sep 2025 | 50,000 | 653,766 | - | 20.0 | 1,000,150 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 12 Sep 2025 | 25,000 | 703,766 | - | 17 | 425,000 | Common Stock |
| Mr. Michael S. Clifton | Director | 12 Sep 2025 | 28,812 | 456,250 | - | - | Warrants (Right to Buy) | ||
| Dr. Ray Johnson, PhD | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 12 Sep 2025 | 126,295 | 293,461 | - | 20 | 2,525,900 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 18.19 per share. | 12 Sep 2025 | 2,649 | 214,584 | - | 18.2 | 48,174 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 19.92 per share. | 12 Sep 2025 | 2,643 | 200,006 | - | 19.9 | 52,647 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 19.27 per share. | 12 Sep 2025 | 11,935 | 202,649 | - | 19.3 | 229,955 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 17.09 per share. | 12 Sep 2025 | 7,773 | 217,233 | - | 17.1 | 132,809 | Common Stock |
| Mr. Michael S. Clifton | Director | 09 Sep 2025 | 25,000 | 485,062 | - | - | Warrants (Right to Buy) | ||
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 09 Sep 2025 | 100,000 | 728,766 | - | 15.4 | 1,539,340 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 20 Aug 2025 | 3,919 | 183,581 | - | 14.8 | 58,149 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 20 Aug 2025 | 44,355 | 730,568 | - | 14.8 | 658,472 | Common Stock |
| Mr. Thomas J. Iannotti | Director | 14 Aug 2025 | 100,000 | 620,000 | - | - | Stock Option (Right to Buy) | ||
| Mr. Thomas J. Iannotti | Director | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 14 Aug 2025 | 100,000 | 14,902 | - | 16.7 | 1,669,870 | Common Stock |
| Mr. Thomas J. Iannotti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. | 14 Aug 2025 | 100,000 | 114,902 | - | 1.2 | 117,000 | Common Stock |
| Mr. Michael S. Clifton | Director | 14 Aug 2025 | 21,188 | 510,062 | - | - | Warrants (Right to Buy) | ||
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 17 Jul 2025 | 25,000 | 828,766 | - | 17 | 425,000 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Jul 2025 | 25,000 | 853,766 | - | 15 | 375,000 | Common Stock |
| Dr. Ray Johnson, PhD | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Jul 2025 | 40,420 | 419,756 | - | 15 | 606,300 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 12.71 per share. | 12 Jun 2025 | 77,284 | 93,991 | - | 12.7 | 981,986 | Common Stock |
| Mr. Michael S. Clifton | Director | 11 Jun 2025 | 25,000 | 531,250 | - | - | Warrants (right to buy) | ||
| Mr. Thomas J. Iannotti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 14,902 | 14,902 | - | 0 | Common Stock | |
| Dr. Alissa M. Fitzgerald, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 14,902 | 171,275 | - | 0 | Common Stock | |
| Dr. Ray Johnson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 14,902 | 460,176 | - | 0 | Common Stock | |
| Ms. Helene Gail Sandford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 14,902 | 225,006 | - | 0 | Common Stock | |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 10 Jun 2025 | 47,648 | 210,104 | - | 11.2 | 532,952 | Common Stock |
| Mr. Michael S. Clifton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 14,902 | 878,766 | - | 0 | Common Stock | |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 09 Jun 2025 | 25,000 | 863,864 | - | 12 | 300,000 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 11.76 per share. | 09 Jun 2025 | 50,000 | 888,864 | - | 11.8 | 588,000 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 11.89 per share. | 21 May 2025 | 44,815 | 774,923 | - | 11.9 | 532,801 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share. | 20 May 2025 | 1,000,000 | 1,000,000 | - | 1.0 | 963,800 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 20 May 2025 | 1,000,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 20 May 2025 | 1,000,000 | 0 | - | 12.0 | 12,004,400 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.89 per share. | 19 May 2025 | 3,848 | 196,152 | - | 11.9 | 45,752 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 19 May 2025 | 218,750 | 418,750 | - | 0.6 | 131,250 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.64 per share. | 19 May 2025 | 218,750 | 200,000 | - | 11.6 | 2,547,191 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.95 per share. | 19 May 2025 | 8,652 | 187,500 | - | 12.0 | 103,392 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | 19 May 2025 | 218,750 | 281,250 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 9.12 per share. | 14 Mar 2025 | 275,000 | 819,738 | - | 9.1 | 2,508,633 | Common Stock |
| Ms. Cathy L. McCarthy | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 11 Mar 2025 | 150,000 | 234,234 | - | 8.0 | 1,200,240 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 200,000 | 200,000 | - | 0 | Common Stock | |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 200,000 | 1,446,523 | - | 0 | Common Stock | |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 10 Mar 2025 | 351,785 | 1,094,738 | - | 7.8 | 2,730,907 | Common Stock |
| Dr. Ray Johnson, PhD | Director | 12 Dec 2024 | 98,373 | 0 | - | - | Stock Option (right to buy) | ||
| Dr. Ray Johnson, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 12 Dec 2024 | 98,373 | 445,274 | - | 0.3 | 26,757 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 10 Dec 2024 | 125,000 | 938,864 | - | 6 | 750,000 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 5.03 per share. | 09 Dec 2024 | 125,000 | 1,063,864 | - | 5.0 | 628,750 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 06 Dec 2024 | 125,000 | 1,188,864 | - | 4 | 500,000 | Common Stock |
| Mr. Michael S. Clifton | Director | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 25 Nov 2024 | 125,000 | 1,313,864 | - | 3 | 375,000 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | Director, President and CEO | 15 Nov 2024 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | GENERAL COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 15 Nov 2024 | 5,982 | 1,036,023 | - | 1.5 | 9,272 | Common Stock |
| Ms. Cathy L. McCarthy | Director | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 15 Nov 2024 | 50,000 | 384,234 | - | 1.6 | 78,000 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 14 Nov 2024 | 29,846 | 1,246,523 | - | 1.5 | 46,261 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 1.64 per share. | 14 Nov 2024 | 60,000 | 1,276,369 | - | 1.6 | 98,400 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 17 Sep 2024 | 43,200 | 257,752 | - | 0.8 | 35,424 | Common Stock |
| Ms. Helene Gail Sandford | Director | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 11 Sep 2024 | 23,162 | 300,952 | - | 0.8 | 17,372 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 09 Sep 2024 | 17,294 | 156,373 | - | 0.8 | 13,835 | Common Stock |
| Mr. Rick Danis | GENERAL COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 14 Aug 2024 | 6,332 | 1,042,005 | - | 0.9 | 5,509 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 14 Aug 2024 | 39,638 | 1,336,369 | - | 0.9 | 34,485 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 12 Aug 2024 | 20,000 | 173,667 | - | 0.8 | 16,400 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 15 Jul 2024 | 20,000 | 193,667 | - | 1.1 | 21,800 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 24 Jun 2024 | 20,000 | 213,667 | - | 1.0 | 19,000 | Common Stock |
| Ms. Cathy L. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 142,857 | 434,234 | - | 0 | Common Stock | |
| Mr. Thomas J. Iannotti | Director | 18 Jun 2024 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | ||
| Mr. Michael S. Clifton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 142,857 | 1,438,864 | - | 0 | Common Stock | |
| Dr. Alissa M. Fitzgerald, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 142,857 | 233,667 | - | 0 | Common Stock | |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 18 Jun 2024 | 50,000 | 90,810 | - | 1 | 50,000 | Common Stock |
| Dr. Ray Johnson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 142,857 | 346,901 | - | 0 | Common Stock | |
| Ms. Helene Gail Sandford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 142,857 | 324,114 | - | 0 | Common Stock | |
| Mr. Rick Danis | GENERAL COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 14 May 2024 | 3,804 | 1,048,337 | - | 1.3 | 5,097 | Common Stock |
| Mr. Rick Danis | GENERAL COUNSEL & CORP. SEC. | 14 May 2024 | 348,600 | 348,600 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 14 May 2024 | 4,433 | 1,376,007 | - | 1.3 | 5,940 | Common Stock |
| Mr. Jeffrey A. Bertelsen | CHIEF FINANCIAL OFFICER | 18 Mar 2024 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | GENERAL COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 18 Mar 2024 | 46,326 | 1,052,141 | - | 2.0 | 91,262 | Common Stock |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 500,000 | 1,380,440 | - | 0 | Common Stock | |
| Mr. David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 18 Mar 2024 | 9,273 | 880,440 | - | 2.0 | 18,268 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | 01 Mar 2024 | 34,747 | 0 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.93 per share. | 01 Mar 2024 | 34,747 | 140,810 | - | 1.9 | 67,062 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 01 Mar 2024 | 34,747 | 175,557 | - | 0.3 | 9,451 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 28 Feb 2024 | 30,000 | 170,810 | - | 0.3 | 8,160 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | 28 Feb 2024 | 30,000 | 34,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 28 Feb 2024 | 30,000 | 140,810 | - | 2.0 | 60,300 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 20 Feb 2024 | 10,000 | 150,810 | - | 0.3 | 2,720 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 20 Feb 2024 | 10,000 | 140,810 | - | 1.8 | 18,300 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | 20 Feb 2024 | 10,000 | 64,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | 12 Feb 2024 | 10,000 | 74,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 12 Feb 2024 | 10,000 | 140,810 | - | 1.5 | 15,000 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 12 Feb 2024 | 10,000 | 150,810 | - | 0.3 | 2,720 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 01 Feb 2024 | 20,000 | 160,810 | - | 0.3 | 5,440 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | 01 Feb 2024 | 20,000 | 84,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 01 Feb 2024 | 20,000 | 140,810 | - | 1.3 | 25,600 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | 30 Jan 2024 | 20,000 | 104,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa M. Fitzgerald, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 30 Jan 2024 | 20,000 | 160,810 | - | 0.3 | 5,440 | Common Stock |
| Dr. Alissa M. Fitzgerald, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 30 Jan 2024 | 20,000 | 140,810 | - | 1.3 | 25,600 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 1.08 per share. | 17 Nov 2023 | 37,765 | 1,098,467 | - | 1.1 | 40,714 | - |
| Mr. David Rivas | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.08 per share. | 17 Nov 2023 | 7,494 | 889,713 | - | 1.1 | 8,081 | - |
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 01 Sep 2023 | 8,000 | 148,810 | - | 0.3 | 2,176 | - |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 01 Sep 2023 | 8,000 | 140,810 | - | 1.8 | 14,400 | - |
| Mr. David Rivas | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 17 Aug 2023 | 7,896 | 897,207 | - | 1.9 | 15,081 | Common Stock |
| Ms. Cathy L. McCarthy | Director | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 15 Aug 2023 | 185,000 | 291,377 | - | 2.4 | 451,400 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | 15 Aug 2023 | 334,100 | 334,100 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | General Counsel & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 15 Aug 2023 | 40,084 | 1,136,232 | - | 1.9 | 76,560 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 01 Aug 2023 | 8,000 | 148,810 | - | 0.3 | 2,176 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 01 Aug 2023 | 8,000 | 132,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 2.86 per share. | 01 Aug 2023 | 8,000 | 140,810 | - | 2.9 | 22,880 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 03 Jul 2023 | 8,000 | 140,810 | - | 1.3 | 10,240 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 03 Jul 2023 | 8,000 | 140,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 03 Jul 2023 | 8,000 | 148,810 | - | 0.3 | 2,176 | Common Stock |
| Ms. Cathy L. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 113,821 | 476,377 | - | 0 | Common Stock | |
| Mr. David John Cowan, L.L.B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 113,821 | 181,257 | - | 0 | Common Stock | |
| Mr. Michael S. Clifton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 113,821 | 1,296,007 | - | 0 | Common Stock | |
| Dr. Alissa Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 113,821 | 140,810 | - | 0 | Common Stock | |
| Dr. Ray Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 113,821 | 204,044 | - | 0 | Common Stock | |
| Ms. Helene Gail Sandford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 113,821 | 181,257 | - | 0 | Common Stock | |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 12 Jun 2023 | 40,447 | 26,989 | - | 1.4 | 57,030 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 08 Jun 2023 | 8,000 | 75,436 | - | 0.3 | 2,176 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 08 Jun 2023 | 8,000 | 148,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 08 Jun 2023 | 8,000 | 67,436 | - | 1.3 | 10,240 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 17 May 2023 | 22,919 | 1,176,316 | - | 0.5 | 11,689 | Common Stock |
| Mr. David Rivas | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 17 May 2023 | 4,233 | 905,103 | - | 0.5 | 2,159 | Common Stock |
| Mr. Jeffrey A. Bertelsen | Chief Financial Officer | 30 Mar 2023 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | General Counsel & Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 454,545 | 1,199,235 | - | 0 | Common Stock | |
| Mr. Rick Danis | General Counsel & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 30 Mar 2023 | 50,871 | 744,690 | - | 0.6 | 28,488 | Common Stock |
| Mr. David Rivas | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 30 Mar 2023 | 19,646 | 309,336 | - | 0.6 | 11,002 | Common Stock |
| Mr. David Rivas | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 600,000 | 909,336 | - | 0 | Common Stock | |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 06 Feb 2023 | 3,869 | 67,436 | - | 1.3 | 4,952 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 06 Feb 2023 | 4,131 | 156,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | 06 Feb 2023 | 3,869 | 160,878 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 06 Feb 2023 | 4,131 | 67,436 | - | 1.3 | 5,288 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 06 Feb 2023 | 4,131 | 71,567 | - | 0.3 | 1,124 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 06 Feb 2023 | 3,869 | 71,305 | - | 0.3 | 1,052 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 20 Dec 2022 | 100,802 | 707,026 | - | 0.3 | 27,418 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | 20 Dec 2022 | 100,802 | 145,016 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | General Counsel & Corp. Sec. | 20 Dec 2022 | 41,316 | 29,513 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | General Counsel & Corp. Sec. | 20 Dec 2022 | 47,219 | 23,610 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | General Counsel & Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 20 Dec 2022 | 47,219 | 795,561 | - | 0.3 | 12,844 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 20 Dec 2022 | 41,316 | 748,342 | - | 0.3 | 11,238 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 6,819 | 998,163 | - | 1.0 | 6,614 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 8,822 | 989,341 | - | 1.0 | 8,557 | Common Stock |
| Dr. Subodh K. Kulkarni,PhD | President and CEO | 12 Dec 2022 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Subodh K. Kulkarni,PhD | President and CEO | 12 Dec 2022 | 1,250,000 | 1,250,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Rick Danis | General Counsel & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 7,247 | 606,224 | - | 1.0 | 7,030 | Common Stock |
| Mr. Rick Danis | General Counsel & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 5,603 | 613,471 | - | 1.0 | 5,435 | Common Stock |
| Dr. Chad Rigetti | Director | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 102,280 | 9,016,480 | - | 1.0 | 99,212 | Common Stock |
| Dr. Chad Rigetti | Director | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 132,289 | 8,884,191 | - | 1.0 | 128,320 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 5,983 | 712,129 | - | 1.0 | 5,804 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 12 Dec 2022 | 4,625 | 718,112 | - | 1.0 | 4,486 | Common Stock |
| Mr. Rick Danis | Interim CEO, GC &Corp. Sec. | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 7,171 | 478,290 | - | 1.0 | 7,386 | - |
| Mr. Rick Danis | Interim CEO, GC &Corp. Sec. | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 07 Dec 2022 | 6,274 | 619,074 | - | 1.0 | 6,337 | - |
| Mr. Rick Danis | Interim CEO, GC &Corp. Sec. | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 10,019 | 485,461 | - | 1.0 | 10,320 | - |
| Mr. Rick Danis | Interim CEO, GC &Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 147,058 | 625,348 | - | 0 | - | |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 8,272 | 733,838 | - | 1.0 | 8,520 | - |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 5,920 | 727,918 | - | 1.0 | 6,098 | - |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 07 Dec 2022 | 5,181 | 722,737 | - | 1.0 | 5,233 | - |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 12,195 | 1,021,350 | - | 1.0 | 12,561 | - |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 8,729 | 1,012,621 | - | 1.0 | 8,991 | - |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 07 Dec 2022 | 7,639 | 1,004,982 | - | 1.0 | 7,715 | - |
| Dr. Chad Rigetti | Director | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 182,904 | 9,364,232 | - | 1.0 | 188,391 | - |
| Dr. Chad Rigetti | Director | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 07 Dec 2022 | 130,919 | 9,233,313 | - | 1.0 | 134,847 | - |
| Dr. Chad Rigetti | Director | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 07 Dec 2022 | 114,553 | 9,118,760 | - | 1.0 | 115,699 | - |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 01 Dec 2022 | 8,000 | 67,436 | - | 1.3 | 10,640 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 01 Dec 2022 | 8,000 | 164,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 01 Dec 2022 | 8,000 | 75,436 | - | 0.3 | 2,176 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 01 Nov 2022 | 8,000 | 67,436 | - | 1.9 | 15,360 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 01 Nov 2022 | 8,000 | 172,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 01 Nov 2022 | 8,000 | 75,436 | - | 0.3 | 2,176 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 03 Oct 2022 | 8,000 | 67,436 | - | 1.8 | 14,640 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 03 Oct 2022 | 8,000 | 180,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 03 Oct 2022 | 8,000 | 75,436 | - | 0.3 | 2,176 | Common Stock |
| Dr. Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 14 Sep 2022 | 8,000 | 67,436 | - | 2.3 | 18,640 | Common Stock |
| Dr. Alissa Fitzgerald | Director | 14 Sep 2022 | 8,000 | 188,747 | - | - | Stock Option (right to buy) | ||
| Dr. Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 14 Sep 2022 | 8,000 | 75,436 | - | 0.3 | 2,176 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.94 per share. | 25 Aug 2022 | 29,903 | 1,064,365 | - | 3.9 | 117,818 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 25 Aug 2022 | 30,820 | 1,033,545 | - | 4.0 | 123,588 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 25 Aug 2022 | 42,049 | 1,094,268 | - | 4.3 | 180,390 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 3.94 per share. | 25 Aug 2022 | 6,198 | 501,872 | - | 3.9 | 24,420 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 25 Aug 2022 | 6,392 | 495,480 | - | 4.0 | 25,632 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 25 Aug 2022 | 8,716 | 508,070 | - | 4.3 | 37,392 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 25 Aug 2022 | 159,353 | 9,777,254 | - | 4.3 | 683,624 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 25 Aug 2022 | 116,800 | 9,547,136 | - | 4.0 | 468,368 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.94 per share. | 25 Aug 2022 | 113,318 | 9,663,936 | - | 3.9 | 446,473 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 25 Aug 2022 | 4,671 | 742,110 | - | 4.0 | 18,731 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 3.94 per share. | 25 Aug 2022 | 4,529 | 746,781 | - | 3.9 | 17,844 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 25 Aug 2022 | 6,370 | 751,310 | - | 4.3 | 27,327 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 22 Aug 2022 | 17,607 | 1,178,367 | - | 4.7 | 81,873 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 22 Aug 2022 | 19,623 | 1,136,317 | - | 4.5 | 89,088 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 22 Aug 2022 | 22,427 | 1,155,940 | - | 4.6 | 102,716 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 22 Aug 2022 | 3,649 | 525,503 | - | 4.7 | 16,968 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 22 Aug 2022 | 4,068 | 516,786 | - | 4.5 | 18,469 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 22 Aug 2022 | 4,649 | 520,854 | - | 4.6 | 21,292 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 22 Aug 2022 | 84,988 | 10,010,971 | - | 4.6 | 389,245 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 22 Aug 2022 | 74,364 | 9,936,607 | - | 4.5 | 337,613 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 22 Aug 2022 | 66,727 | 10,095,959 | - | 4.7 | 310,281 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 22 Aug 2022 | 3,397 | 760,653 | - | 4.6 | 15,558 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 22 Aug 2022 | 2,667 | 764,050 | - | 4.7 | 12,402 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 22 Aug 2022 | 2,973 | 757,680 | - | 4.5 | 13,497 | Common Stock |
| Mr. Michael S. Clifton | Director | 16 Aug 2022 | 556,250 | 556,250 | - | - | Warrant (right to buy) | ||
| Mr. Michael S. Clifton | Director | Other type of transaction at price $ 0.00 per share. | 16 Aug 2022 | 1,052,250 | 1,182,186 | - | 0 | Common Stock | |
| Mr. Gregory John Peters | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 350,000 | 350,000 | - | 0 | Common Stock | |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 15 Jun 2022 | 1,583 | 1,196,150 | - | 4.4 | 7,044 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 15 Jun 2022 | 176 | 1,195,974 | - | 4.6 | 803 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.46 per share. | 15 Jun 2022 | 14,353 | 533,346 | - | 4.5 | 64,014 | Common Stock |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 15 Jun 2022 | 4,194 | 529,152 | - | 4.6 | 19,125 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 15 Jun 2022 | 256,574 | 10,212,510 | - | 4.4 | 1,141,754 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 15 Jun 2022 | 49,824 | 10,162,686 | - | 4.6 | 227,197 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 15 Jun 2022 | 16,844 | 769,425 | - | 4.5 | 74,956 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 15 Jun 2022 | 2,708 | 766,717 | - | 4.6 | 12,348 | Common Stock |
| Mr. Brian Sereda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,000 | 1,197,955 | - | 0 | Common Stock | |
| Mr. Brian Sereda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 128,600 | 1,192,955 | - | 0 | Common Stock | |
| Mr. Brian Sereda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 8,791 | 1,064,355 | - | 0 | Common Stock | |
| Mr. Brian Sereda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Jun 2022 | 222 | 1,197,733 | - | 4.4 | 983 | Common Stock |
| Ms. Cathy L. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 26,974 | 362,556 | - | 0 | Common Stock | |
| Ms. Cathy L. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,462 | 335,582 | - | 0 | Common Stock | |
| Mr. David John Cowan, L.L.B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 26,974 | 67,436 | - | 0 | Common Stock | |
| Mr. David John Cowan, L.L.B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,462 | 40,462 | - | 0 | Common Stock | |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 553,417 | - | 0 | Common Stock | |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 164,685 | 425,617 | - | 0 | Common Stock | |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 102,800 | 528,417 | - | 0 | Common Stock | |
| Mr. Rick Danis | General Counsel and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Jun 2022 | 5,718 | 547,699 | - | 4.4 | 25,331 | Common Stock |
| Mr. Michael S. Clifton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 26,974 | 129,936 | - | 0 | Common Stock | |
| Mr. Michael S. Clifton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,462 | 102,962 | - | 0 | Common Stock | |
| Dr. Chad Rigetti | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 334,700 | 10,556,308 | - | 0 | Common Stock | |
| Dr. Chad Rigetti | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 2,857,444 | 10,221,608 | - | 0 | Common Stock | |
| Dr. Chad Rigetti | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Jun 2022 | 132,224 | 10,469,084 | - | 4.4 | 585,752 | Common Stock |
| Dr. Chad Rigetti | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 45,000 | 10,601,308 | - | 0 | Common Stock | |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 107,900 | 795,407 | - | 0 | Common Stock | |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Jun 2022 | 9,138 | 786,269 | - | 4.4 | 40,481 | Common Stock |
| Mr. Mike Harburn | SVP, Fabrication Ops. Hardware | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 207,178 | 687,507 | - | 0 | Common Stock | |
| Dr. Alissa Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,462 | 40,462 | - | 0 | Common Stock | |
| Dr. Alissa Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 26,974 | 67,436 | - | 0 | Common Stock | |
| Dr. Ray Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 26,974 | 90,223 | - | 0 | Common Stock | |
| Dr. Ray Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,462 | 63,249 | - | 0 | Common Stock | |
| Ms. Helene Gail Sandford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 26,974 | 67,436 | - | 0 | Common Stock | |
| Ms. Helene Gail Sandford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,462 | 40,462 | - | 0 | Common Stock | |
| Mr. Michael S. Clifton | Director | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 02 Mar 2022 | 62,500 | 62,500 | - | 10 | 625,000 | Common Stock |